Fatal Hyperpyrexia After Withdrawal of Levodopa
Neurol 34:249-251, Sechi,G.P.,et al, 1984
Meige's Syndrome During Long-term Dopaminergic Therapy in Parkinson's Disease
Arch Neurol 39:451-452, Weiner,W.J.,et al, 1982
Drug-induced Asterixis in Parkinson Disease
Neurol 32:553-555, Glantz,R.,et al, 1982
Complications of Chronic Levodopa Therapy; Long-term Efficacy of Drug Holiday
Neurol 31:473-476, Koller,W.C.,et al, 1981
Sinemet & the Treatment of Parkinsonism
Ann Int Med 94:364-370, Boshes,B., 1981
Parkinsonism With`On-Off'Phenomena-Intravenous Treatment With Levodopa After Major Abdominal Surgery
Arch Neurol 36:32-34, Rosin,A.J.,et al, 1979
Analysis of the Clinical Problems in Parkinsonism & the Complications of Long-term Levodopa Therapy
Neurol 29:1253-1260, Lesser,R.P.,et al, 1979
Dementia in Parkinson Disease
Ann Neurol 6:355-359, Lieberman,A.,et al, 1979
Early-Morning Dystonia-A Late Side Effect of Long-Term Levodopa Therapy
Arch Neurol 36:308-310, Melamed,E., 1979
The L-Dopa On-Off Effect in Parkinson Disease:Treat. by Trans. Drug Withdrawal & Dopamine Receptor Resens
Ann Neurol 4:573-575, Direnfeld,L.,et al, 1978
Respiratory Dyskinesias:Extrapyramidal Dysfunction & Dyspnea
Ann Int Med 88:327, Weiner,W.J.,et al, 1978
Considerations in the Management of Parkinsonism
Neurol 28:5, Fahn,S.,et al, 1978
Onset & End-of-dose Levodopa-induced Dyskinesias
Arch Neurol 35:261, Lhermitte,F.,et al, 1978
Drug Therapy of Parkinsonism
NEJM 295:814, Bianchine,J.R., 1976
Drugs that Reduce Efficacy of Levodopa
(Letter) , NEJM 295:153876., Hausner,R., 1976
Levodopa-Induced Myoclonus
Arch Neurol 32:331-334, Klawans,H.L., 1975
Prolonged Levodopa Therapy
BMJ 383, Feb 1973., , 1973
Start Hesitation-A Side Effect of Long-Term Levodopa Therapy
NEJM 288:1113, Ambani,L.,et al, 1973
Occurence of Positive Coombs Test in Patients Treated with Levodopa
NEJM 286:1401, Joseph,C., 1972
Methyldopahydrazine as an Adjunct to L-Dopa Therapy in Parkinsonism
Neurol 22:384, Chase,T.,et al, 1972
Metabolic Responses to Acute & Chronic L-Dopa Administration in Patients with Parkinsonism
NEJM 287:729, Sirtori,C.,et al, 1972
Drug Therapy of Parkinsonism
NEJM 287:20, Yahr,M.,et al, 1972
Modern Treatment of Parkinson's Disease
Excerpta Medica 2:1972 Aug., , 1972
Modern Treatment of Parkinson's Disease
Excerpta Medica, 2:1971 Jun-Jul., , 1971
Drug-Induced Movement Disorders
Postgrad Med 180, 1971, Sept., North,R., 1971
Manic Response to Levodopa Therapy
NEJM 285:788, Ryback,R.,et al, 1971
Monoamine Oxidase Inhibitor & L-Dopa
BMJ 3:388, Hunter,H.R.,et al, 1970
Juvenile-Onset Dopa-Responsive Dystonia-Until It Isnt
Neurol 104:e213436, Paredes,N.C.,et al, 2025
Parkinsons Disease
NEJM 391:442-452, Tanner,C.M. & Ostrem,J.L., 2024
A Young Woman With Hypertonia, Severe Scoliosis, and Encephalopathy
JAMA Neurol 81:83-84, Hua,L.,et al, 2024
A 6-Year-Old Girl with Progressive Toe Walking
Neurol 98:e769-e773, Libdeh, A.A. & Ibrahim, A., 2022
Diagnosis and Treatment of Parkinson Disease
JAMA 323:548-560, Armstrong, M.J. & Okun, M.S., 2020
Vitamin B6 Deficiency Presenting with New-Onset Epilepsy and Status Epilepticus in a Patient with Parkinson Disease
Neurol 94:e2605-e2607, Modica, J.S.,et al, 2020
When to Start Levodopa Therapy for Parkinsons Disease
NEJM 380:389-390, Bressman, S. & Saunders-Pullman, R., 2019
Safety and Efficacy of Focused Ultrasound Thalamotomy for Patients with Medication-Refractory, Tremor-Dominant Parkinson Disease
JAMA Neurol 74:1412-1418, Bond, A.E.,et al, 2017
A 56-year-old Man with Cognitive Impairment and Difficulty Tying his Necktie
Neurol 85:e116-e122, Baker, J.M.,et al, 2015
Parkinsons Disease Beyond 20 Years
JNNP 86:849-855, Cilia, R.,et al, 2015
Long-Term Effectivenss of Dopamine Agonists and Monoamine Oxidase B Inhibitors Compared with Levodopa as Initial Treatment for Parkinsons Disease (PD MED): A Large, Open-Label, Pragmatic Randomised Trial
Lancet 383: Doi: 10.1016/S0140-6736, PD MED Collaborative Group, 2014
Disturbances of Cerebrospinal Fluid, Including Hydrocephalus, Pseudotumor Cerebri, and Low-Pressure Syndromes, Parkinsonism and Midbrain Syndromes with Hydrocephalus and Shunting
Adams & Victors Principles of Neurology, Chp 30, pg 627, Ropper, A.H.,et al, 2014
Degenerative Diseases of the Nervous System, Parkinson Disease
Adams & Victors Principles of Neurology, Chp 39, pg 1082, Ropper, A.H.,et al, 2014
Criteria for the Diagnosis of Corticobasal Degeneration
Neurol 80:496-503, Armstrong, M.J.,et al, 2013
Parkin Disease
JAMA Neurol 70:571-579, Doherty, K.,et al, 2013
Deep-Brain Stimulation for Parkinsons Disease
NEJM 367:1529-1538, Okon, M.S., 2012
Dopa-Responsive Dystonia Revisited
Arch Neurol 69:1558-1562, Tadic, V.,et al, 2012
Deep Brain Stimulation for Parkinson Disease: An Expert Consensus and Review of Key Issues
Arch Neurol 68:165-171, Bronstein,J.M.,et al, 2011
Clinicopath Conf, Rapid-Onset-Dystonia-Parkinsonism Due to a Mutation in the ATP1A3 Gene
NEJM 362:2213-2219, Case 17-2010, 2010
A Meta-Regression of the Long-Term Effects of Deep Brain Stimulation on Balance and Gait in PD
Neurol 75:1292-1299, St. George,R.J.,et al, 2010
Othello Syndrome in Parkinson Disease Patients Without Dementia
The Neurologist 15:34-36, Cannas,A.,et al, 2009
Parkinsons Disease
Lancet 373:2055-2066, Lees,A.J.,et al, 2009
Progressive Supranuclear Palsy: A Current Review
The Neurologist 14:79-88, Lubarsky,M. &Juncos,J.L., 2008